Species-specific antibiotic-ribosome interactions: implications for drug development

Abstract In the cell, the protein synthetic machinery is a highly complex apparatus that offers many potential sites for functional interference and therefore represents a major target for antibiotics. The recent plethora of crystal structures of ribosomal subunits in complex with various antibiotics has provided unparalleled insight into their mode of interaction and inhibition. However, differences in the conformation, orientation and position of some of these drugs bound to ribosomal subunits of Deinococcus radiodurans (D50S) compared to Haloarcula marismortui (H50S) have raised questions regarding the species specificity of binding. Revisiting the structural data for the bacterial D50S-antibiotic complexes reveals that the mode of binding of the macrolides, ketolides, streptogramins and lincosamides is generally similar to that observed in the archaeal H50S structures. However, small discrepancies are observed, predominantly resulting from species-specific differences in the ribosomal proteins and rRNA constituting the drug-binding sites. Understanding how these small alterations at the binding site influence interaction with the drug will be essential for rational design of more potent inhibitors.

[1]  Gregor Blaha,et al.  Structures of MLSBK Antibiotics Bound to Mutated Large Ribosomal Subunits Provide a Structural Explanation for Resistance , 2005, Cell.

[2]  M. Perić,et al.  In Vitro Selection of Resistance in Haemophilus influenzae by Amoxicillin-Clavulanate, Cefpodoxime, Cefprozil, Azithromycin, and Clarithromycin , 2002, Antimicrobial Agents and Chemotherapy.

[3]  M. Di Giambattista,et al.  Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic. , 1989, Biochimica et biophysica acta.

[4]  A. Bashan,et al.  Structure of trigger factor binding domain in biologically homologous complex with eubacterial ribosome reveals its chaperone action. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Tateda,et al.  In Vivo Efficacy of Telithromycin (HMR3647) againstStreptococcus pneumoniae and Haemophilus influenzae , 2001, Antimicrobial Agents and Chemotherapy.

[6]  A. Mankin.  Ribosomal Antibiotics , 2004, Molecular Biology.

[7]  G. Bertho,et al.  Lincomycin and clindamycin conformations. A fragment shared by macrolides, ketolides and lincosamides determined from TRNOE ribosome-bound conformations. , 2000, Bioorganic & medicinal chemistry.

[8]  N. Ban,et al.  The chemistry of protein synthesis and voyage through the ribosomal tunnel. , 2003, Current opinion in structural biology.

[9]  M. Di Giambattista,et al.  Competition between erythromycin and virginiamycin for in vitro binding to the large ribosomal subunit. , 1981, Biochimica et biophysica acta.

[10]  A Yonath,et al.  Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3 , 2001, The EMBO journal.

[11]  Marina V. Rodnina,et al.  Structural Basis for the Function of the Ribosomal L7/12 Stalk in Factor Binding and GTPase Activation , 2005, Cell.

[12]  J. Poehlsgaard,et al.  The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059. , 2004, Journal of molecular biology.

[13]  S. T. Gregory,et al.  Erythromycin resistance mutations in ribosomal proteins L22 and L4 perturb the higher order structure of 23 S ribosomal RNA. , 1999, Journal of molecular biology.

[14]  S. Osawa,et al.  Biochemical and genetic studies on two different types of erythromycin resistant mutants of Escherichia coli with altered ribosomal proteins , 1973, Molecular and General Genetics MGG.

[15]  R. Garrett,et al.  Fine structure of the peptidyl transferase centre on 23 S-like rRNAs deduced from chemical probing of antibiotic-ribosome complexes. , 1995, Journal of molecular biology.

[16]  A. Mankin,et al.  A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre , 1999, Molecular microbiology.

[17]  R. Garrett,et al.  Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23 S rRNA and the synergism of their inhibitory mechanisms. , 1999, Journal of molecular biology.

[18]  C. Cocito,et al.  Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Poehlsgaard,et al.  Macrolide antibiotic interaction and resistance on the bacterial ribosome. , 2003, Current opinion in investigational drugs.

[20]  V. Ramakrishnan,et al.  Recognition of Cognate Transfer RNA by the 30S Ribosomal Subunit , 2001, Science.

[21]  F. Schluenzen,et al.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.

[22]  W. S. Champney,et al.  Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli , 1994, Journal of bacteriology.

[23]  A. Bogdanov,et al.  Peptide Derivatives of Antibiotics Tylosin and Desmycosin, Protein Synthesis Inhibitors , 2003, Biochemistry (Moscow).

[24]  P. Vannuffel,et al.  The role of rRNA bases in the interaction of peptidyltransferase inhibitors with bacterial ribosomes. , 1992, The Journal of biological chemistry.

[25]  A. Mankin,et al.  Binding Site of Macrolide Antibiotics on the Ribosome: New Resistance Mutation Identifies a Specific Interaction of Ketolides with rRNA , 2001, Journal of bacteriology.

[26]  S. Douthwaite,et al.  Activity of the Ketolide Telithromycin Is Refractory to Erm Monomethylation of Bacterial rRNA , 2002, Antimicrobial Agents and Chemotherapy.

[27]  Thomas A Steitz,et al.  Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. , 2003, Journal of molecular biology.

[28]  Daniel N. Wilson.  Antibiotics and the Inhibition of Ribosome Function , 2006 .

[29]  P. Vannuffel,et al.  Inhibition of protein synthesis by streptogramins and related antibiotics. , 1997, The Journal of antimicrobial chemotherapy.

[30]  M. Ehrenberg,et al.  Regulatory Nascent Peptides in the Ribosomal Tunnel , 2002, Cell.

[31]  F. Schluenzen,et al.  Structure of Functionally Activated Small Ribosomal Subunit at 3.3 Å Resolution , 2000, Cell.

[32]  H. Bartels,et al.  Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin , 2004, BMC Biology.

[33]  S. Douthwaite.  Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA. , 1992, Nucleic acids research.

[34]  N. Ban,et al.  Trigger factor in complex with the ribosome forms a molecular cradle for nascent proteins , 2004, Nature.

[35]  V. Ramakrishnan,et al.  Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics , 2000, Nature.

[36]  V. Ramakrishnan,et al.  Crystal structure of an initiation factor bound to the 30S ribosomal subunit. , 2001, Science.

[37]  Daniel N. Wilson,et al.  The binding mode of the trigger factor on the ribosome: Implications for protein folding and SRP interaction , 2005, Structure.

[38]  R. Leclercq,et al.  Diversity of Ribosomal Mutations Conferring Resistance to Macrolides, Clindamycin, Streptogramin, and Telithromycin in Streptococcus pneumoniae , 2002, Antimicrobial Agents and Chemotherapy.

[39]  Poul Nissen,et al.  The structures of four macrolide antibiotics bound to the large ribosomal subunit. , 2002, Molecular cell.

[40]  G. Dinos,et al.  Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex. , 2001, Molecular pharmacology.

[41]  C. Vonrhein,et al.  Structure of the 30S ribosomal subunit , 2000, Nature.

[42]  R. Berisio,et al.  Structural Insight into the Antibiotic Action of Telithromycin against Resistant Mutants , 2003, Journal of bacteriology.

[43]  F. Schluenzen,et al.  X‐ray crystallography study on ribosome recycling: the mechanism of binding and action of RRF on the 50S ribosomal subunit , 2005, The EMBO journal.

[44]  F. Schluenzen,et al.  Structure of Functionally Activated Small Ribosomal Subunit , 2000 .

[45]  T. Steitz,et al.  The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. , 2000, Science.

[46]  Frank Schluenzen,et al.  High Resolution Structure of the Large Ribosomal Subunit from a Mesophilic Eubacterium , 2001, Cell.

[47]  P. Courvalin,et al.  Mutation in 23S rRNA Responsible for Resistance to 16-Membered Macrolides and Streptogramins in Streptococcus pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.

[48]  M. Newcomer,et al.  A response to reimportation. , 2005, Structure.

[49]  Rachel Green,et al.  The Active Site of the Ribosome Is Composed of Two Layers of Conserved Nucleotides with Distinct Roles in Peptide Bond Formation and Peptide Release , 2004, Cell.

[50]  F. Franceschi,et al.  Macrolide resistance from the ribosome perspective. , 2004, Current drug targets. Infectious disorders.

[51]  R. Zarivach,et al.  Structural basis for the antibiotic activity of ketolides and azalides. , 2003, Structure.

[52]  T. Steitz,et al.  Gene replacement in Haloarcula marismortui: construction of a strain with two of its three chromosomal rRNA operons deleted , 2005, Extremophiles.

[53]  P. Vannuffel,et al.  Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain. , 1994, Nucleic acids research.